BiotechTube
Home/Pipeline/Oncology 1

Oncology 1

Not Specified (Oncology)

Pre-clinicalActive

Key Facts

Indication
Not Specified (Oncology)
Phase
Pre-clinical
Status
Active
Company
Actipulse Neuroscience

About Actipulse Neuroscience

Actipulse Neuroscience is a clinical-stage neurotech company developing novel non-invasive brain stimulation devices for central nervous system disorders. Backed by Y Combinator and operating as a Paris Brain Institute company, it leverages a proprietary platform of high-frequency magnetic pulse technology. Its lead program for Major Depressive Disorder is in Phase 3, with a preclinical pipeline targeting oncology and other CNS conditions. The company aims to become the gold standard in neuromodulation within five years.

View full company profile

Therapeutic Areas

PsychiatryNeurologyOncology

Other Not Specified (Oncology) Drugs

DrugCompanyPhase
IMGS-203ImmunoGenesisPre-clinical
XNW28012Evopoint BiosciencesPhase 3
Anti-TM4SF4 AntibodyAlgok BioPreclinical
SynKIR™-310Verismo TherapeuticsPhase 1
AUR112Aurigene OncologyPhase 1
B7H3 Antibody-Drug ConjugateEllipses PharmaClinical
BC3448BioCity BiopharmaPhase 1
BC2027BioCity BiopharmaPhase 1